OBZEO Trademark

Trademark Overview

On Wednesday, July 1, 2026, a trademark application was filed for OBZEO with the United States Patent and Trademark Office. The USPTO has given the OBZEO trademark a serial number of 99916692. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 1, 2026. This trademark is owned by Zenas BioPharma, Inc.. The OBZEO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for medical purposes, namely, immunology-based therapies for autoimmune diseases; Pharmaceutical and biological preparations for use in inflammation, immunology, rheumatology, neurology, gastroenterology, dermatology, and hematology for medical purposes; Therapeutic agents, namely, monoclonal antibodies for inhibiting the production and proliferation of autoantibodies, cytokine secretion, and other inflammatory proteins, and antigen uptake for medical purposes; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing autoimmune diseases, inflammatory diseases, immunoglobulin G4-related disease (IgG4-RD), multiple sclerosis, lupus, autoimmune hemolytic anemia, rheumatoid arthritis, and diseases, disorders, and conditions of the immune system
obzeo

General Information

Serial Number99916692
Word MarkOBZEO
Filing DateWednesday, July 1, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, July 1, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of three translucent irregular overlapping ovals to the left of the term OBZEO.
Goods and ServicesPharmaceutical and biological preparations for medical purposes, namely, immunology-based therapies for autoimmune diseases; Pharmaceutical and biological preparations for use in inflammation, immunology, rheumatology, neurology, gastroenterology, dermatology, and hematology for medical purposes; Therapeutic agents, namely, monoclonal antibodies for inhibiting the production and proliferation of autoantibodies, cytokine secretion, and other inflammatory proteins, and antigen uptake for medical purposes; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing autoimmune diseases, inflammatory diseases, immunoglobulin G4-related disease (IgG4-RD), multiple sclerosis, lupus, autoimmune hemolytic anemia, rheumatoid arthritis, and diseases, disorders, and conditions of the immune system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 1, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZenas BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
US

Trademark Events

Event DateEvent Description
Wednesday, July 1, 2026NEW APPLICATION ENTERED
Wednesday, July 1, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

obzeo diseases pharmaceutical purposes autoimmune preparations medical biological inflammatory namely immunology